The clinical management of bacterial infections has become a growing global public health
challenge. Such therapy is presently limited to antibiotics, but the misuse of antibiotics has …

Breast cancer is one of the most common cancers among women that is associated with
high mortality. Conventional treatments including surgery, radiotherapy, and chemotherapy …

The clinical employment of cisplatin (cis‐diamminedichloroplatinum (II)(CDDP)) is largely
constrained due to the non‐specific delivery and resultant serious systemic toxicity. Small …

Blood loss by hemorrhaging wounds accounts for over one-third of∼ 5 million trauma
fatalities worldwide every year. If not controlled in a timely manner, exsanguination can take …

Immunogenic cell death (ICD, also known as immunogenic apoptosis) of malignant cells is
confirmed to activate the host immune system to prevent, control, and eliminate tumors …

Inefficient tumor accumulation and penetration remain as the main challenges to therapy
efficacy of lung cancer. Local delivery of smart nanoclusters can increase drug penetration …

Reactive oxygen species (ROS) produced by noble metallic nanoparticles under visible light
is an effective way to combat drug-resistant bacteria colonized on the wound. However, the …

Natural products and analogues are a source of antibacterial drug discovery. Considering
drug resistance levels emerging for antibiotics, identification of bacterial metalloenzymes …

Lung cancer is the second most prevalent cancer and the leading cause of cancer‐related
death worldwide. Surgery, chemotherapy, molecular targeted therapy, immunotherapy, and …

Nanoclays, 2D layered mineral silicates, have been used for centuries and have retained a
prominent role in advancing materials science and technology. This class of materials has …